Evolving use and indications for implantable cardioverter defibrillators.
作者信息
de Groot J R
机构信息
Department of Cardiology, Amsterdam University Medical Centers/University of Amsterdam, Heart Center, Amsterdam, The Netherlands.
出版信息
Neth Heart J. 2018 Dec;26(12):581-583. doi: 10.1007/s12471-018-1193-2.
Abstract
摘要
相似文献
1
Evolving use and indications for implantable cardioverter defibrillators.植入式心脏复律除颤器的使用演变及适应证
Neth Heart J. 2018 Dec;26(12):581-583. doi: 10.1007/s12471-018-1193-2.
2
Implantable cardioverter-defibrillator: present and future indications.植入式心脏复律除颤器：当前及未来的适应症
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7.
3
Implantable cardioverter-defibrillator advances.植入式心脏复律除颤器的进展。
Curr Opin Cardiol. 1996 Jan;11(1):16-22. doi: 10.1097/00001573-199601000-00004.
4
Implantable cardioverter-defibrillators: expanding indications.植入式心脏复律除颤器：适应证不断扩大。
Curr Opin Cardiol. 2004 Jul;19(4):317-22. doi: 10.1097/01.hco.0000129666.57492.45.
5
Organisation of care for Swedish patients with an implantable cardioverter defibrillator, a national survey.瑞典植入式心脏除颤器患者的护理组织，全国性调查。
J Clin Nurs. 2011 Sep;20(17-18):2600-8. doi: 10.1111/j.1365-2702.2010.03540.x. Epub 2010 Oct 21.
6
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.比较单腔和双腔植入式心脏复律除颤器在预防心源性猝死中的不适当电击和其他健康结局：心血管研究网络植入式心脏复律除颤器纵向研究的结果。
J Am Heart Assoc. 2017 Nov 9;6(11):e006937. doi: 10.1161/JAHA.117.006937.
7
Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.植入式心脏复律除颤器对晚期心力衰竭女性心脏性猝死一级预防的有效性：一项随机对照试验的荟萃分析。
Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.
8
Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.心力衰竭患者植入式心脏复律除颤器的停用：一项系统评价
J Hosp Palliat Nurs. 2018 Feb;20(1):63-71. doi: 10.1097/NJH.0000000000000399.
9
Dual-chamber implantable cardioverter-defibrillators for nonpacing indications: comment on "variation in use of dual-chamber implantable cardioverter defibrillators".
Arch Intern Med. 2012 Apr 23;172(8):641. doi: 10.1001/archinternmed.2012.710.
10
Quality of life and psychological status of patients with implantable cardioverter defibrillators.植入式心脏复律除颤器患者的生活质量和心理状态
Am J Crit Care. 2006 Jul;15(4):389-98.
本文引用的文献
1
Influence of permanent pacemaker implantation after transcatheter aortic valve implantation with new-generation devices.新一代装置经导管主动脉瓣植入术后永久性起搏器植入的影响
Neth Heart J. 2018 Dec;26(12):620-627. doi: 10.1007/s12471-018-1194-1.
2
Magnetic resonance imaging in patients with cardiac implantable electronic devices.心脏植入式电子设备患者的磁共振成像
Neth Heart J. 2018 Dec;26(12):584-590. doi: 10.1007/s12471-018-1192-3.
3
Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients.小儿及青年经静脉和皮下植入式心脏复律除颤器患者并发症与休克的比较。
Neth Heart J. 2018 Dec;26(12):612-619. doi: 10.1007/s12471-018-1186-1.
4
Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design.植入式心脏复律除颤器与冠状动脉疾病患者的无症状性心房颤动（INDICO AF）试验：研究原理与设计
Neth Heart J. 2018 Dec;26(12):628-633. doi: 10.1007/s12471-018-1185-2.
5
Device updates successfully reduce T‑wave oversensing and inappropriate shocks in subcutaneous ICD patients.设备更新成功减少了皮下植入式心律转复除颤器（ICD）患者的T波过度感知和不适当电击。
Neth Heart J. 2018 Dec;26(12):606-611. doi: 10.1007/s12471-018-1160-y.
6
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.探索心房高率发作患者的口服抗凝治疗：心房高率发作患者非维生素K拮抗剂口服抗凝剂（NOAH-AFNET 6）试验的原理与设计
Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.
7
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.阿哌沙班用于降低器械检测到的亚临床房颤患者血栓栓塞事件（ARTESiA）试验的原理与设计
Am Heart J. 2017 Jul;189:137-145. doi: 10.1016/j.ahj.2017.04.008. Epub 2017 Apr 24.
8
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.因T波过度感知导致的不适当皮下植入式心律转复除颤器电击可被预防：对管理的启示
Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.
9
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.
10
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.从近乎致命的室性心律失常中复苏的患者，抗心律失常药物治疗与植入式除颤器的比较。
N Engl J Med. 1997 Nov 27;337(22):1576-83. doi: 10.1056/NEJM199711273372202.
Zotero 插件